Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v10-EN | Version v2-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2023-07-18 | 2023-04-11 |
| Drug Identification Number | 02457539 | 02457539 |
| Brand name | JAMP DORZOLAMIDE-TIMOLOL | JAMP DORZOLAMIDE-TIMOLOL |
| Common or Proper name | Dorzolamide and Timolol eye drops | Dorzolamide and Timolol eye drops |
| Company Name | JAMP PHARMA CORPORATION | JAMP PHARMA CORPORATION |
| Ingredients | TIMOLOL DORZOLAMIDE | TIMOLOL DORZOLAMIDE |
| Strength(s) | 5MG 20MG | 5MG 20MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | OPHTHALMIC OPHTHALMIC | OPHTHALMIC OPHTHALMIC |
| Packaging size | 10 | 10 |
| ATC code | S01ED | S01ED |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2023-04-11 | 2023-04-11 |
| Estimated end date | 2023-07-14 | 2023-06-30 |
| Actual end date | 2023-07-17 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Increase in demand. Under allocation | Increase in demand. Under allocation |
| Health Canada comments |